| RS1569359535 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1569359540 |
SMC1A
|
Health Risk |
Likely pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Thyroid cancer |
| RS1569360089 |
HPRT1
|
Health Risk |
Pathogenic |
Lesch-Nyhan syndrome, Lesch-Nyhan syndrome |
| RS1569360139 |
HPRT1
|
Health Risk |
Likely pathogenic |
Lesch-Nyhan syndrome, HPRT1-related disorder |
| RS1569364701 |
PHEX
|
Health Risk |
Pathogenic |
Hypophosphataemia or rickets, Hypophosphataemia or rickets |
| RS1569369194 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS1569369653 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1569369940 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS1569370887 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1569371303 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1569371330 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS1569371591 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS1569376084 |
CASK
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, CASK-related |
| RS1569376229 |
CD40LG
|
Health Risk |
Likely pathogenic |
Hyper-IgM syndrome type 1, Common variable immunodeficiency |
| RS1569376447 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1569376809 |
DYRK1A
|
Health Risk |
Likely pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1569376925 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS1569376930 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS1569377237 |
CD40LG
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS1569377829 |
CD40LG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS1569377865 |
CD40LG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyper-IgM syndrome type 1, Hyper-IgM syndrome type 1 |
| RS1569380062 |
CASK
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Najm type, Congenital cerebellar hypoplasia |
| RS1569380375 |
DYRK1A
|
Health Risk |
Likely pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1569384962 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1569385075 |
CUL4B
|
Health Risk |
Likely pathogenic |
— |
| RS1569389364 |
CUL4B
|
Health Risk |
Likely pathogenic |
X-linked intellectual disability Cabezas type, X-linked intellectual disability Cabezas type |
| RS1569390220 |
CUL4B
|
Health Risk |
Pathogenic |
— |
| RS1569390976 |
CUL4B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1569391212 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1569392947 |
GPC3
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS1569394026 |
ARX
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked |
| RS1569395541 |
ARX
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS1569398234 |
DYRK1A
|
Health Risk |
Conflicting classifications of pathogenicity |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1569398276 |
EFNB1
|
Health Risk |
Pathogenic |
— |
| RS1569398624 |
HUWE1
|
Health Risk |
Likely pathogenic |
— |
| RS1569398769 |
PAK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 30 |
| RS1569398792 |
PAK3
|
Health Risk |
Likely pathogenic |
History of neurodevelopmental disorder, History of neurodevelopmental disorder |
| RS1569399945 |
HUWE1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked syndromic |
| RS1569401103 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569402390 |
ELF4
|
Health Risk |
Likely pathogenic |
— |
| RS1569404780 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1569404873 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1569404950 |
EDA
|
Health Risk |
Likely pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1569405174 |
AMMECR1
|
Health Risk |
Pathogenic |
Short stature, Midface hypoplasia |
| RS1569406514 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1569407150 |
EDA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1569407346 |
EDA
|
Health Risk |
Pathogenic |
Hypohidrotic X-linked ectodermal dysplasia, Hypohidrotic X-linked ectodermal dysplasia |
| RS1569408743 |
GPC3
|
Health Risk |
Pathogenic |
Wilms tumor 1, Wilms tumor 1 |
| RS1569418673 |
AIFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
AIFM1-related hypomyelination with spondylometaphyseal dysplasia, Spondyloepimetaphyseal dysplasia |
| RS1569420470 |
ACSL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 63 |
| RS1569420537 |
SPECC1L
|
Health Risk |
Pathogenic |
Teebi hypertelorism syndrome, Teebi hypertelorism syndrome |
| RS1569420568 |
SPECC1L
|
Health Risk |
Pathogenic |
Teebi hypertelorism syndrome 1, Teebi hypertelorism syndrome |
| RS1569420590 |
SPECC1L
|
Health Risk |
Pathogenic |
Teebi hypertelorism syndrome, Teebi hypertelorism syndrome 1 |
| RS1569420596 |
SPECC1L
|
Health Risk |
Pathogenic |
Teebi hypertelorism syndrome, Teebi hypertelorism syndrome |
| RS1569420861 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569423317 |
ACSL4
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 63 |
| RS1569426054 |
GPC3
|
Health Risk |
Likely pathogenic |
Simpson-Golabi-Behmel syndrome type 1, Simpson-Golabi-Behmel syndrome type 1 |
| RS1569427275 |
PLP1
|
Health Risk |
Likely pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS1569427311 |
PLP1
|
Health Risk |
Pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS1569427535 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1569427707 |
PLP1
|
Health Risk |
Likely pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS1569428537 |
PLP1
|
Health Risk |
Likely pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS1569429756 |
CASK
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, CASK-related |
| RS1569431986 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1569434045 |
PHEX
|
Health Risk |
Pathogenic |
Hypophosphatemic rickets, Hypophosphatemic rickets |
| RS1569438496 |
SPECC1L
|
Health Risk |
Likely pathogenic |
Teebi hypertelorism syndrome, Teebi hypertelorism syndrome |
| RS1569439669 |
RBMX
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1569442206 |
PHEX
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1569442989 |
GRIA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Syndromic X-linked intellectual disability 94, Neurodevelopmental disorder |
| RS1569451994 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569452000 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569458475 |
ARHGEF9
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 8 |
| RS1569458883 |
OCRL
|
Health Risk |
Pathogenic/Likely pathogenic |
Lowe syndrome, Dent disease type 2 |
| RS1569459580 |
PAK3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Thyroid cancer |
| RS1569460607 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569460610 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569460722 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569463775 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Dent disease type 2 |
| RS1569463838 |
NDUFA6
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 33 |
| RS1569463953 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569464167 |
UPF3B
|
Health Risk |
Pathogenic |
— |
| RS1569469138 |
DMD
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1569469298 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1569469409 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1569469484 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS1569474795 |
FTSJ1
|
Health Risk |
Likely pathogenic |
— |
| RS1569476483 |
ARHGEF9
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 8 |
| RS1569477854 |
PORCN
|
Health Risk |
Likely pathogenic |
— |
| RS1569477871 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS1569478551 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1569479610 |
EBP
|
Health Risk |
Likely pathogenic |
Chondrodysplasia punctata 2 X-linked dominant, Chondrodysplasia punctata 2 X-linked dominant |
| RS1569479885 |
EBP
|
Health Risk |
Pathogenic |
Chondrodysplasia punctata 2 X-linked dominant, Chondrodysplasia punctata 2 X-linked dominant |
| RS1569479901 |
EBP
|
Health Risk |
Pathogenic |
Chondrodysplasia punctata 2 X-linked dominant, Chondrodysplasia punctata 2 X-linked dominant |
| RS1569479913 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS1569479943 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1569479953 |
CYBB
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS1569479994 |
IL2RG
|
Health Risk |
Likely pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS1569480016 |
EBP
|
Health Risk |
Pathogenic |
Chondrodysplasia punctata 2 X-linked dominant, Chondrodysplasia punctata 2 X-linked dominant |
| RS1569480018 |
IL2RG
|
Health Risk |
Pathogenic |
X-linked severe combined immunodeficiency, X-linked severe combined immunodeficiency |
| RS1569480031 |
CYBB
|
Health Risk |
Pathogenic/Likely pathogenic |
Granulomatous disease, chronic |